CBNPC CANCER

Clinical trials for CBNPC CANCER explained in plain language.

Never miss a new study

Get alerted when new CBNPC CANCER trials appear

Sign up with your email to follow new studies for CBNPC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Lung cancer study pulled before starting: new combo therapy trial withdrawn

Disease control Terminated

This study aimed to test a combination of two drugs (atezolizumab and tiragolumab) in people with advanced lung cancer that has special immune cell clusters called tertiary lymphoid structures. It planned to include patients who had not received prior treatment or who had already…

Matched conditions: CBNPC CANCER

Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated May 26, 2026 11:59 UTC

CBNPC CANCER

Get alerted when new CBNPC CANCER trials appear

Lung cancer study pulled before starting: new combo therapy trial withdrawn